Education
About Us
Working with TipRanks
Follow Us
Biotricity (BTCY)
:BTCY
BTCY Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.19 - $1.02
Previous CloseN/A
Volume50.15K
Average Volume (3M)26.71K
Market Cap
$12.67M
Enterprise Value$43.14M
Total Cash (Recent Filing)$509.60K
Total Debt (Recent Filing)$25.46M
Price to Earnings (P/E)―
Beta-0.31
Next Earnings
Jun 27, 2025EPS Estimate
-0.1Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.05
Shares Outstanding24,751,757
10 Day Avg. Volume37,291
30 Day Avg. Volume26,708
Financial Highlights & Ratios
PEG Ratio0.03
Price to Book (P/B)-1.22
Price to Sales (P/S)0.00
P/FCF Ratio-1.78
Enterprise Value/Market Cap3.40
Enterprise Value/Revenue0.86
Enterprise Value/Gross Profit4.38
Enterprise Value/Ebitda-1.49
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering0
Biotricity News
PremiumCompany Announcements
Biotricity Reports Revenue Growth Amidst Financial Challenges
PremiumCompany Announcements
Biotricity Notifies Delay in Quarterly Report Filing
PremiumCompany Announcements
Biotricity Reports Revenue Growth Amidst Ongoing Losses
Bulls Say, Bears Say
Bulls Say
Financial PerformanceBiotricity reported a doubling of free cash flow compared to FY2Q25 on an 11% increase in sales to $3.6M.
Operating EfficiencyBiotricity achieved further operating efficiency improvements, with gross margin rising to 76.4%, up from 75.3% in FY2Q25.
Patent AcquisitionPatent acquisition enhances Biotricity’s competitive profile in multi-sensor monitoring.
Bears Say
Investment RisksInvestment in Biotricity carries risks common to small-cap companies, such as dilution and competition.
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
―
Mutual Funds
0.19% Other Institutional Investors
99.81% Public Companies and
Individual Investors
BTCY FAQ
What was Biotricity ’s price range in the past 12 months?
Biotricity lowest stock price was $0.19 and its highest was $1.02 in the past 12 months.
What is Biotricity ’s market cap?
Biotricity ’s market cap is $12.67M.
When is Biotricity ’s upcoming earnings report date?
Biotricity ’s upcoming earnings report date is Jun 27, 2025 which is in 8 days.
How were Biotricity ’s earnings last quarter?
Biotricity released its earnings results on Feb 20, 2025. The company reported -$0.054 earnings per share for the quarter, beating the consensus estimate of -$0.11 by $0.056.
Is Biotricity overvalued?
According to Wall Street analysts Biotricity ’s price is currently Overvalued.
Does Biotricity pay dividends?
Biotricity does not currently pay dividends.
What is Biotricity ’s EPS estimate?
Biotricity ’s EPS estimate is -0.1.
How many shares outstanding does Biotricity have?
Biotricity has 24,751,757 shares outstanding.
What happened to Biotricity ’s price movement after its last earnings report?
Biotricity reported an EPS of -$0.054 in its last earnings report, beating expectations of -$0.11. Following the earnings report the stock price went down -3.03%.
Which hedge fund is a major shareholder of Biotricity ?
Currently, no hedge funds are holding shares in BTCY
Company Description
Biotricity
Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions primarily in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, California.
BTCY Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call presents a predominantly positive outlook with significant achievements in EBITDA, revenue growth, strategic partnerships, and market expansion. Despite the continued net loss, the improvements and strategic advancements position Biotricity well for future profitability.Read More>